查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1831884

2025 年至 2033 年干癣性关节炎治疗市场报告（按药物类型（非类固醇抗发炎药、缓解风湿性关节炎药物、生物製剂及其他）、类型、给药途径、配销通路和地区划分）

Psoriatic Arthritis Treatment Market Report by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type, Route of Administration, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2024年全球干癣性关节炎治疗市场规模达105亿美元。展望未来， IMARC Group预计到2033年市场规模将达到232亿美元，2025-2033年期间的成长率（CAGR）为8.71%。

银屑病关节炎是一种自体免疫疾病，免疫系统攻击关节并引起发炎。其治疗方法多种多样，从减轻肿胀和发炎的口服药物到针对特定免疫系统的生物疗法。治疗方案根据疼痛、肿胀和僵硬程度而定。目前，主要参与者正在推出新的治疗方法，以帮助预防疾病进展、减轻疼痛、保护关节并保持关节活动范围。这些方法可以与物理治疗相结合，以增强肌肉和关节功能，并提高整体稳定性。

银屑病关节炎治疗市场趋势：

银屑病是干癣性关节炎的主要危险因子之一。因此，由于感染、压力、肥胖、皮肤损伤、酗酒和维生素缺乏导致银屑病患病率不断上升，是影响市场的主要因素之一。此外，由于干癣性关节炎最常发生在 30 至 50 岁之间的人群中，全球成年人口的成长也促进了市场的成长。除此之外，患有干癣性关节炎的儿童更容易患上影响眼壁中层组织的葡萄膜炎。这一点，加上父母对孩子健康的日益关注，正在催化全球对干癣性关节炎治疗的需求。此外，人们越来越意识到早期诊断和治疗干癣性关节炎的好处，例如可以预防严重损害，这也促进了市场的成长。其他因素，例如个人可支配收入的增加、医疗设施的改善以及个人健康意识的增强，预计将推动对新型干癣性关节炎治疗的需求，以对抗严重症状。

本报告回答的关键问题：

  • 全球干癣性关节炎治疗市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对全球干癣性关节炎治疗市场有何影响？
  • 主要的区域市场有哪些？
  • 根据药物类型，市场是如何分類的？
  • 根据类型，市场区隔是怎样的？
  • 根据行政路径，市场如何划分？
  • 根据配销通路，市场是如何分類的？
  • 该产业的价值链分为哪些阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球干癣性关节炎治疗市场的结构是怎么样的？主要参与者是谁？
  • 产业竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球银屑病关节炎治疗市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依药物类型

  • 非类固醇抗发炎药（NSAIDs）
  • DMARDs（改善病情的抗风湿药物）
  • 生物製剂
  • 其他的

第七章：市场区隔：依类型

  • 处方
  • 场外交易

第八章：市场区隔：依行政途径

  • 注射剂
  • 口服
  • 外用

第九章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eisai Co. Ltd.
    • Eli Lilly and Company
    • Johnson & Johnson Service ltd.
    • Novartis AG
    • Pfizer Inc.
    • Samsung Biologics
    • UCB SA
Product Code: SR112025A4541

The global psoriatic arthritis treatment market size reached USD 10.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.2 Billion by 2033, exhibiting a growth rate (CAGR) of 8.71% during 2025-2033.

Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary from oral medications that reduce swelling and inflammation to biological therapies that target the specific immune system. It is treated as per the level of pain, swelling, and stiffness. At present, key players are introducing new treatment methods that help prevent disease progression, reduce pain, protect joints, and preserve the range of motion. These methods can be combined with physical therapy to strengthen muscles and joints and increase overall stability.

Psoriatic Arthritis Treatment Market Trends:

Psoriasis disease is one of the major risk factors for psoriatic arthritis. As a result, the increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively. Moreover, as psoriatic arthritis occurs most commonly among individuals between the ages of 30 and 50, the rising adult population worldwide is contributing to the market growth. Apart from this, children with psoriatic arthritis are more likely to develop uveitis that affects the middle layer of tissue in the eyewall. This, in confluence with the growing concerns among parents about the health of their children, is catalyzing the demand for psoriatic arthritis treatment across the globe. In addition, the rising awareness about the benefits of early diagnosis and treatment of psoriatic arthritis, such as preventing serious damages, is bolstering the market growth. Other factors, such as inflating disposable income of individuals, improvement in healthcare facilities, and the growing health awareness among individuals, are anticipated to drive the demand for novel psoriatic arthritis treatment to combat severe symptoms.

Key Market Segmentation:

Breakup by Drug Type:

  • NSAIDs (Nonsteroidal Anti-Inflammatory drugs)
  • DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others

Breakup by Type:

  • Prescription
  • OTC

Breakup by Route of Administration:

  • Injectable
  • Oral
  • Topical

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.

Key Questions Answered in This Report:

  • How has the global psoriatic arthritis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global psoriatic arthritis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global psoriatic arthritis treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Psoriatic Arthritis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biologics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Prescription
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 OTC
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amneal Pharmaceuticals LLC
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 AstraZeneca plc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eisai Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Eli Lilly and Company
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Service ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Samsung Biologics
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 UCB S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Psoriatic Arthritis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Psoriatic Arthritis Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Psoriatic Arthritis Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 5: Global: Psoriatic Arthritis Treatment Market: Breakup by Type (in %), 2024
  • Figure 6: Global: Psoriatic Arthritis Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Psoriatic Arthritis Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Psoriatic Arthritis Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Psoriatic Arthritis Treatment (Biologics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Psoriatic Arthritis Treatment (Biologics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Psoriatic Arthritis Treatment (Prescription) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Psoriatic Arthritis Treatment (Prescription) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Psoriatic Arthritis Treatment (OTC) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Psoriatic Arthritis Treatment (OTC) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Psoriatic Arthritis Treatment (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Psoriatic Arthritis Treatment (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Psoriatic Arthritis Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Psoriatic Arthritis Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Psoriatic Arthritis Treatment (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Psoriatic Arthritis Treatment (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Psoriatic Arthritis Treatment Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Psoriatic Arthritis Treatment Industry: SWOT Analysis
  • Figure 83: Global: Psoriatic Arthritis Treatment Industry: Value Chain Analysis
  • Figure 84: Global: Psoriatic Arthritis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Psoriatic Arthritis Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 3: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 4: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Psoriatic Arthritis Treatment Market: Competitive Structure
  • Table 8: Global: Psoriatic Arthritis Treatment Market: Key Players